Skip to Content
Merck
  • Stereoselective synthesis of trans- and cis-2-aryl-3-(hydroxymethyl)aziridines through transformation of 4-aryl-3-chloro-beta-lactams and study of their ring opening.

Stereoselective synthesis of trans- and cis-2-aryl-3-(hydroxymethyl)aziridines through transformation of 4-aryl-3-chloro-beta-lactams and study of their ring opening.

Organic & biomolecular chemistry (2010-01-22)
Matthias D'hooghe, Karen Mollet, Stijn Dekeukeleire, Norbert De Kimpe
ABSTRACT

trans- and cis-1-Alkyl-4-aryl-3-chloroazetidin-2-ones, prepared through cyclocondensation of chloroketene and the appropriate imines in a diastereoselective way, were transformed into the corresponding non-activated trans- and cis-2-aryl-3-(hydroxymethyl)aziridines via reductive ring contraction using LiAlH(4) in Et(2)O. Furthermore, trans-2-aryl-3-(hydroxymethyl)aziridines were transformed into 2-amino-3-arylpropan-1-ols and anti-2-amino-3-aryl-3-methoxypropan-1-ols by means of an unprecedented ring opening by LiAlH(4) and by MeOH, respectively. cis-2-Aryl-3-(hydroxymethyl)aziridines were shown to be highly reluctant to undergo ring opening by LiAlH(4) and MeOH under similar reaction conditions.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Lithium aluminum hydride solution, 2.0 M in THF
Sigma-Aldrich
Lithium aluminum hydride solution, 1.0 M in diethyl ether
Sigma-Aldrich
Lithium aluminum hydride solution, 1.0 M in THF
Sigma-Aldrich
Lithium aluminum hydride solution, 2.3 M in 2-methyltetrahydrofuran